91 related articles for article (PubMed ID: 9121364)
1. In vivo consequences of M1-receptor activation by talsaclidine.
Walland A; Burkard S; Hammer R; Tröger W
Life Sci; 1997; 60(13-14):977-84. PubMed ID: 9121364
[TBL] [Abstract][Full Text] [Related]
2. Compensation of muscarinic bronchial effects of talsaclidine by concomitant sympathetic activation in guinea pigs.
Walland A; Palluk R; Burkard S; Hammer R
Eur J Pharmacol; 1997 Jul; 330(2-3):213-9. PubMed ID: 9253956
[TBL] [Abstract][Full Text] [Related]
3. Central activation of the sympathetic nervous system including the adrenals in anaesthetized guinea pigs by the muscarinic agonist talsaclidine.
Walland A; Pieper MP
Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):426-30. PubMed ID: 9606029
[TBL] [Abstract][Full Text] [Related]
4. Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine.
Terry AV; Buccafusco JJ; Borsini F; Leusch A
Psychopharmacology (Berl); 2002 Jul; 162(3):292-300. PubMed ID: 12122487
[TBL] [Abstract][Full Text] [Related]
5. Functional characterization of peripheral muscarinic subtypes in anesthetized cats.
Koss MC
Life Sci; 1997; 61(2):217-27. PubMed ID: 9217280
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain.
Müller DM; Mendla K; Farber SA; Nitsch RM
Life Sci; 1997; 60(13-14):985-91. PubMed ID: 9121365
[TBL] [Abstract][Full Text] [Related]
7. WAL 2014--a muscarinic agonist with preferential neuron-stimulating properties.
Ensinger HA; Doods HN; Immel-Sehr AR; Kuhn FJ; Lambrecht G; Mendla KD; Müller RE; Mutschler E; Sagrada A; Walther G
Life Sci; 1993; 52(5-6):473-80. PubMed ID: 8441328
[TBL] [Abstract][Full Text] [Related]
8. M1, M3 and M5 muscarinic receptors stimulate mitogen-activated protein kinase.
Wotta DR; Wattenberg EV; Langason RB; el-Fakahany EE
Pharmacology; 1998 Apr; 56(4):175-86. PubMed ID: 9566019
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man.
Wienrich M; Meier D; Ensinger HA; Gaida W; Raschig A; Walland A; Hammer R
Life Sci; 2001 Apr; 68(22-23):2593-600. PubMed ID: 11392631
[TBL] [Abstract][Full Text] [Related]
10. Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry.
Wood MD; Murkitt KL; Ho M; Watson JM; Brown F; Hunter AJ; Middlemiss DN
Br J Pharmacol; 1999 Apr; 126(7):1620-4. PubMed ID: 10323594
[TBL] [Abstract][Full Text] [Related]
11. Effects of central muscarinic-1 receptor stimulation on blood pressure regulation.
Medina A; Bodick N; Goldberger AL; Mac Mahon M; Lipsitz LA
Hypertension; 1997 Mar; 29(3):828-34. PubMed ID: 9052903
[TBL] [Abstract][Full Text] [Related]
12. G(q/11) and G(i/o) activation profiles in CHO cells expressing human muscarinic acetylcholine receptors: dependence on agonist as well as receptor-subtype.
Akam EC; Challiss RA; Nahorski SR
Br J Pharmacol; 2001 Feb; 132(4):950-8. PubMed ID: 11181437
[TBL] [Abstract][Full Text] [Related]
13. Beta-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling.
Züchner T; Perez-Polo JR; Schliebs R
J Neurosci Res; 2004 Jul; 77(2):250-7. PubMed ID: 15211591
[TBL] [Abstract][Full Text] [Related]
14. 6beta-Acetoxynortropane: a potent muscarinic agonist with apparent selectivity toward M2-receptors.
Pei XF; Gupta TH; Badio B; Padgett WL; Daly JW
J Med Chem; 1998 Jun; 41(12):2047-55. PubMed ID: 9622546
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
Arnt J; Lembøl HL; Meier E; Pedersen H
Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
[TBL] [Abstract][Full Text] [Related]
16. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
[TBL] [Abstract][Full Text] [Related]
17. M1 muscarinic receptor signaling in mouse hippocampus and cortex.
Porter AC; Bymaster FP; DeLapp NW; Yamada M; Wess J; Hamilton SE; Nathanson NM; Felder CC
Brain Res; 2002 Jul; 944(1-2):82-9. PubMed ID: 12106668
[TBL] [Abstract][Full Text] [Related]
18. Muscarinic M1 receptor activation reduces maximum upstroke velocity of action potential in mouse right atria.
Islam MA; Nojima H; Kimura I
Eur J Pharmacol; 1998 Apr; 346(2-3):227-36. PubMed ID: 9652364
[TBL] [Abstract][Full Text] [Related]
19. M1 receptor agonist activity is not a requirement for muscarinic antinociception.
Sheardown MJ; Shannon HE; Swedberg MD; Suzdak PD; Bymaster FP; Olesen PH; Mitch CH; Ward JS; Sauerberg P
J Pharmacol Exp Ther; 1997 May; 281(2):868-75. PubMed ID: 9152396
[TBL] [Abstract][Full Text] [Related]
20. Mixed agonist-antagonist properties of clozapine at different human cloned muscarinic receptor subtypes expressed in Chinese hamster ovary cells.
Olianas MC; Maullu C; Onali P
Neuropsychopharmacology; 1999 Mar; 20(3):263-70. PubMed ID: 10063486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
